Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kian Ang

Showing results (111-120 of 206) with videos related to

Pageof 21
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 30, 2005
Concomitant boost radiation plus concurrent cisplatin for advanced head and neck carcinomas: radiation therapy oncology group phase II trial 99-14K Kian Ang, Jonathan Harris, Adam S Garden, et al.
International Journal of Radiation Oncology, Biology, Physics|July 22, 2008
Long-term results of concomitant boost radiation plus concurrent cisplatin for advanced head and neck carcinomas: a phase II trial of the radiation therapy oncology group (RTOG 99-14)Adam S Garden, Jonathan Harris, Andy Trotti, et al.
The Laryngoscope|September 2, 2006
Laryngeal cancer in the United States: changes in demographics, patterns of care, and survivalHenry T Hoffman, Kimberly Porter, Lucy H Karnell, et al.
International Journal of Radiation Oncology, Biology, Physics|February 13, 2007
Endostatin improves radioresponse and blocks tumor revascularization after radiation therapy for A431 xenografts in miceSatoshi Itasaka, Ritsuko Komaki, Roy S Herbst, et al.
International Journal of Radiation Oncology, Biology, Physics|June 23, 2009
Multi-institutional trial of accelerated hypofractionated intensity-modulated radiation therapy for early-stage oropharyngeal cancer (RTOG 00-22)Avraham Eisbruch, Jonathan Harris, Adam S Garden, et al.
Head & Neck|November 4, 2009
Anaplastic thyroid cancer: Clinical outcomes with conformal radiotherapyAarti Bhatia, Archana Rao, Kie-Kian Ang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 2009
Intensity-modulated radiation therapy with or without chemotherapy for nasopharyngeal carcinoma: radiation therapy oncology group phase II trial 0225Nancy Lee, Jonathan Harris, Adam S Garden, et al.
International Journal of Radiation Oncology, Biology, Physics|June 12, 2012
The American Board of Radiology Holman Research Pathway: 10-year retrospective review of the program and participant performancePaul E Wallner, K Kian Ang, Anthony L Zietman, et al.
International Journal of Radiation Oncology, Biology, Physics|May 6, 2008
Beam path toxicities to non-target structures during intensity-modulated radiation therapy for head and neck cancerDavid I Rosenthal, Mark S Chambers, Clifton D Fuller, et al.
Head & Neck|May 31, 2013
Clinical characteristics of patients with multiple potentially human papillomavirus-related malignanciesHeath D Skinner, Erich M Sturgis, Ann H Klopp, et al.
Pageof 21

Showing results (111-120 of 206) with videos related to

Sort By:
Pageof 21
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 30, 2005
Concomitant boost radiation plus concurrent cisplatin for advanced head and neck carcinomas: radiation therapy oncology group phase II trial 99-14K Kian Ang, Jonathan Harris, Adam S Garden, et al.
International Journal of Radiation Oncology, Biology, Physics|July 22, 2008
Long-term results of concomitant boost radiation plus concurrent cisplatin for advanced head and neck carcinomas: a phase II trial of the radiation therapy oncology group (RTOG 99-14)Adam S Garden, Jonathan Harris, Andy Trotti, et al.
The Laryngoscope|September 2, 2006
Laryngeal cancer in the United States: changes in demographics, patterns of care, and survivalHenry T Hoffman, Kimberly Porter, Lucy H Karnell, et al.
International Journal of Radiation Oncology, Biology, Physics|February 13, 2007
Endostatin improves radioresponse and blocks tumor revascularization after radiation therapy for A431 xenografts in miceSatoshi Itasaka, Ritsuko Komaki, Roy S Herbst, et al.
International Journal of Radiation Oncology, Biology, Physics|June 23, 2009
Multi-institutional trial of accelerated hypofractionated intensity-modulated radiation therapy for early-stage oropharyngeal cancer (RTOG 00-22)Avraham Eisbruch, Jonathan Harris, Adam S Garden, et al.
Head & Neck|November 4, 2009
Anaplastic thyroid cancer: Clinical outcomes with conformal radiotherapyAarti Bhatia, Archana Rao, Kie-Kian Ang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 2009
Intensity-modulated radiation therapy with or without chemotherapy for nasopharyngeal carcinoma: radiation therapy oncology group phase II trial 0225Nancy Lee, Jonathan Harris, Adam S Garden, et al.
International Journal of Radiation Oncology, Biology, Physics|June 12, 2012
The American Board of Radiology Holman Research Pathway: 10-year retrospective review of the program and participant performancePaul E Wallner, K Kian Ang, Anthony L Zietman, et al.
International Journal of Radiation Oncology, Biology, Physics|May 6, 2008
Beam path toxicities to non-target structures during intensity-modulated radiation therapy for head and neck cancerDavid I Rosenthal, Mark S Chambers, Clifton D Fuller, et al.
Head & Neck|May 31, 2013
Clinical characteristics of patients with multiple potentially human papillomavirus-related malignanciesHeath D Skinner, Erich M Sturgis, Ann H Klopp, et al.
Pageof 21